NASDAQ:DRDB · NASDAQ Global Select
-$0.01 today
Vol 0.19M · Avg 0.12M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Company filings are the primary source for understanding what changed inside Roman DBDR Acquisition Corp. II before the market fully reacts. Review recent DRDB disclosures alongside price history and peer context to identify new risks, accounting changes, strategic updates, capital allocation decisions, and operating details that may affect the intrinsic value case.
Price History
Dividend-adjusted closing price
Change
+3.12%
Period High
$10.58
Period Low
$10.25
Latest
$10.58
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
Drugs Made In America Acquisition Corp. Ordinary Shares
NASDAQ:DMAA
$359.09M
Andretti Acquisition Corp. II
NASDAQ:POLE
$318.41M
Hennessy Capital Investment Corp. VII
NASDAQ:HVII
$272.20M
Plum Acquisition Corp. IV
NASDAQ:PLMK
$258.67M
FACT II Acquisition Corp
NASDAQ:FACT
$258.54M
Rithm Acquisition Corp.
NYSE:RAC
$248.67M
Sizzle Acquisition Corp. II
NASDAQ:SZZL
$244.97M
Highview Merger Corp.
NASDAQ:HVMCU
$243.93M
Newbury Street II Acquisition Corp
NASDAQ:NTWO
$193.30M
Range Capital Acquisition Corp.
NASDAQ:RANG
$171.52M
What is the latest DRDB filing?
The latest filing shown is 8-K dated Jun 2, 2026.
How many recent filings does DRDB have?
Intrinsic Alpha currently shows 20 recent filings for DRDB.
Explore More
Continue the stock analysis
Jump to another research area for this company.